Outlook Therapeutics, Inc. Common Stock (OTLK) is a publicly traded Healthcare sector company. As of July 16, 2026, OTLK trades at $1.47 with a market cap of $231.80M and a P/E ratio of -1.30. OTLK moved -7.05% today. Year to date, OTLK is -7.59%; over the trailing twelve months it is -39.42%. Its 52-week range spans $0.16 to $5.18. Analyst consensus is buy with an average price target of $5.81. Rallies surfaces OTLK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover OTLK: 0 strong buy, 1 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $5.81.
| Metric | Value |
|---|---|
| Price | $1.47 |
| Market Cap | $231.80M |
| P/E Ratio | -1.30 |
| EPS | $-1.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.18 |
| 52-Week Low | $0.16 |
| Volume | 6.24M |
| Avg Volume | 0 |
| Revenue (TTM) | $176.08K |
| Net Income | $-60.96M |
| Gross Margin | -682.73% |
2 analysts cover OTLK: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.81.